Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Accord Healthcare Recalls a Single Batch of Irbesartan 300mg Tablets Due to Incorrect Strength Labelling
Accord Healthcare is recalling a single batch of Irbesartan 300mg film-coated tablets because the blister foil on a small number of blisters is incorrectly labelled as Irbesartan 150mg. All other labelling is correct and the tablets in the blisters are 300mg strength. The affected batch number is P02924. Irbesartan is used to treat high blood pressure, and kidney disease in patients with high blood pressure and type 2 diabetes. For more information please visit: http://www.mhra.gov.uk/Publications/Safetywarnings/DrugAlerts/CON357124
Learn More

Acetylcysteine: Aurum Pharmaceuticals Limited Warns About Ampoule Contamination
Aurum Pharmaceuticals Limited has notified the Medicines and Healthcare products Regulatory Agency (MHRA) that black particles have been found in a very small number of ampoules from batch number 80455 and 90114 of Acetylcysteine 200mg/ml Injection. Investigation has confirmed that the particles are made of carbonised material which forms if droplets of solution are present during sealing of the ampoules. Particles may be suspended in the solution, or may adhere to the inner wall of the ampoule neck. In order to avoid stock shortages, these batches are not being recalled. The company is instructing healthcare professionals to inspect the product as per normal practices during preparation and discard any affected ampoules. Acetylcysteine is most commonly used in the hospital setting to treat paracetamol overdose. It is sometimes used as nebuliser treatment to help break up mucus in the lungs. For more information, please visit: http://www.mhra.gov.uk/Publications/Safetywarnings/DrugAlerts/CON085059
Learn More

Date Published Title Medicine Source
2013-12-24 Accord Healthcare Recalls a Single Batch of Irbesartan 300mg Tablets Due to Incorrect Strength Labelling Irbesartan MHRA
2010-06-25 Acetylcysteine: Aurum Pharmaceuticals Limited Warns About Ampoule Contamination Acetylcysteine Manufacturer
2014-01-06 ALK-Abelló Recalls Jext Injections Over Potentially Faulty Auto Injectors Primatene MHRA
2010-10-21 All Avandia and Avandamet Product Recalled From Pharmacies and Clinics Rosiglitazone MHRA
2011-08-27 All Batches of Nurofen Plus Recalled Due to Rogue Tablets Found In Some Packs Solpaflex MHRA
2010-07-20 Alupent Syrup No Longer Available After July 2010 Orciprenaline Manufacturer
2012-05-24 Anapen Injection Recalled Due To Potential Fault With Autoinjector Primatene MHRA
2010-06-14 Angiotensin-Receptor Blockers (ARBs) May Be Linked to Small Increased Risk of Cancer Telmisartan MediGuard CRT
2010-06-08 Antidepressants During Pregnancy: Rare Risk of Persistent Pulmonary Hypertension in the Newborn Paroxetine MHRA
2010-09-23 Antipsychotic Medicines May Raise Blood Clot Risk Sertindole MediGuard CRT
2012-06-29 Aspire Pharma Launches Generic Version of Leflunomide Leflunomide Manufacturer
2011-10-25 Astellas Recalls Two Batches of Advagraf Due to Possible Incorrect Dose Tacrolimus Manufacturer
2011-03-10 AstraZeneca To Stop Making Pulmicort CFC-free Inhalers Budesonide Inhalation MHRA
2011-05-12 AstraZeneca UK Ltd Recalls Single Batch Of Zoladex 3.6mg Implant Zoladex MHRA
2010-08-12 Available Fabrazyme Supply for July to September Cut in Half Agalsidase Beta Manufacturer
2012-01-18 Bacterial Contamination Leads to Recall of Sterimar Isotonic Nasal Spray Sterimar MHRA
2011-06-03 Bausch & Lomb Recall Single Batch of Minims Dexamethasone Eye Drops Dexamethasone MHRA
2012-12-11 Bausch & Lomb Recalls Minims Proxymetacaine 0.5% Eye Drops Over Contamination Risk Proxymetacaine MHRA
2011-06-22 Bayer Recalls Canesten Pessary Due To Patient Information Leaflet Error Clotrimazole MHRA
2012-04-05 Benlysta Linked To Severe Or Life-Threatening Allergic and Infusion Reactions Manufacturer